Protagonist Therapeutics, Inc.PTGXNASDAQ
Loading
Other Income/Expenses (Net) Over TimeStrong
Percentile Rank100
3Y CAGR+93.5%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+93.5%/yr
vs +11.8%/yr prior
Acceleration
+81.6pp
Accelerating
Percentile
P100
Near historical high
vs 3Y Ago
7.2x
Strong expansion
Streak
5 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$28.82M+8.5%
2024$26.57M+80.8%
2023$14.70M+269.3%
2022$3.98M+1253.7%
2021$294000.00+189.4%
2020$-329000.00-112.4%
2019$2.64M+3.8%
2018$2.55M+170.9%
2017$940000.00+120.8%
2016$-4.51M-